Johnson & Johnson, Boston Scientific and Abbott were among the companies showcasing new data on atrial fibrillation ...

Hospital demand for IV solutions in the U.S. is lower than before Hurricane Helene, the company said.

Surgeons interested in robotic technology but wanting a simpler system than existing platforms are the target market for the new device.

Abbott on Friday presented one-year clinical trial results for the Volt pulsed field ablation system alongside six-month CE ...

Orthopedics was the most active area over the second half of 2025, with the FDA issuing 13 breakthrough designations to ...

Johnson & Johnson’s Abiomed has sent an urgent medical device correction about a malfunction risk linked to 22 reports of ...

The purchase will give Medtronic a larger presence in the cath lab, with a tool to help diagnose and treat coronary artery ...

Amid the upheaval, Grail continued to run studies to assess the ability of its Galleri blood test to detect a range of ...

Healthcare providers are advised to stop using the devices after a failure to detach was linked with four serious injuries ...

Stryker expects the robot, called Mako RPS, to bring in new customers, including more ambulatory surgery centers.

Spending on the tests, which analyze genetic material from both people and pathogens, rose 20% year over year in 2024, the ...

The full financial impact of the price hikes could exceed $67 million each year in two dozen markets, according to the new ...